Adaptimmune Therapeutics (ADAP) Fail-to-Deliver (FTD) Analysis | Settlement Risk & Short Interest - Stocknear

Adaptimmune Therapeutics

NASDAQ: ADAP · Real-Time Price · USD
0.28
-0.00 (-1.06%)
At close: Jun 09, 2025, 3:58 PM

Adaptimmune Therapeutics Fail-to-Deliver

Total FTD Shares
440.48K
Above Average
FTD / Avg. Volume
23.89%
High Impact
1-Year Change
> 100%
Positive Trend

FTD Chart

As of May 14, 2025, Adaptimmune Therapeutics has 440,479 shares failed to deliver, representing 23.89% of the average daily volume of 1,843,711 shares.

FTD History

Date Price FTD Shares % Change
May 14, 2025 0.25 440,479 +2766.58%
Apr 25, 2025 0.27 15,366 +22.50%
Mar 28, 2025 0.22 12,544 -16.37%
Feb 04, 2025 0.59 15,000 +14.61%
Jan 31, 2025 0.61 13,088 +510.73%
Dec 06, 2024 0.67 2,143 +29.56%
Nov 19, 2024 0.60 1,654 -90.90%
Oct 10, 2024 0.89 18,169 +10.77%
Sep 30, 2024 0.98 16,402 +451.70%
Aug 22, 2024 1.19 2,973 -79.34%
Jul 30, 2024 1.37 14,392 -84.01%
Jun 25, 2024 0.88 90,000 +17900.00%
May 30, 2024 1.01 500 +98.41%
Apr 30, 2024 1.15 252 -98.20%
Mar 28, 2024 1.58 14,000 +466566.67%
Feb 21, 2024 1.26 3 -80.00%
Jan 24, 2024 0.76 15 -89.36%
Dec 28, 2023 0.72 141 -89.63%
Nov 15, 2023 0.49 1,360 -77.71%
Oct 25, 2023 0.61 6,101 +1794.72%
Sep 28, 2023 0.80 322 -94.55%
Aug 09, 2023 0.86 5,904 +1394.68%
Jul 31, 2023 0.89 395 -79.84%
Jun 30, 2023 0.94 1,959 +68.59%
May 30, 2023 1.11 1,162 -94.52%
Apr 28, 2023 1.36 21,213 -24.64%
Mar 30, 2023 1.06 28,150 +66923.81%
Feb 14, 2023 1.55 42 -96.55%
Jan 24, 2023 1.75 1,218 n/a